» Articles » PMID: 16492975

Human Milk Oligosaccharides Inhibit the Adhesion to Caco-2 Cells of Diarrheal Pathogens: Escherichia Coli, Vibrio Cholerae, and Salmonella Fyris

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2006 Feb 24
PMID 16492975
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Breast-fed children, compared with the bottle-fed ones, have a lower incidence of acute gastroenteritis due to the presence of several antiinfective factors in human milk. The aim of this work is to study the ability of human milk oligosaccharides to prevent infections related to some common pathogenic bacteria. Oligosaccharides of human milk were fractionated by gel-filtration and characterized by thin-layer chromatography and high-performance anion exchange chromatography. Fractions obtained contained, respectively, 1) acidic oligosaccharides, 2) neutral high-molecular-weight oligosaccharides, and 3) neutral low-molecular-weight oligosaccharides. Experiments were carried out to study the ability of oligosaccharides in inhibiting the adhesion of three intestinal microorganisms (enteropathogenic Escherichia coli serotype O119, Vibrio cholerae, and Salmonella fyris) to differentiated Caco-2 cells. The study showed that the acidic fraction had an antiadhesive effect on the all three pathogenic strains studied (with different degrees of inhibition). The neutral high-molecular-weight fraction significantly inhibited the adhesion of E. coli O119 and V. cholerae, but not that of S. fyris; the neutral low-molecular-weight fraction was effective toward E. coli O119 and S. fyris but not V. cholerae. Our results demonstrate that human milk oligosaccharides inhibit the adhesion to epithelial cells not only of common pathogens like E. coli but also for the first time of other aggressive bacteria as V. cholerae and S. fyris. Consequently, oligosaccharides are one of the important defensive factors contained in human milk against acute diarrheal infections of breast-fed infants.

Citing Articles

Recent advances in the science of human milk oligosaccharides.

Urashima T, Ajisaka K, Ujihara T, Nakazaki E BBA Adv. 2025; 7:100136.

PMID: 39991261 PMC: 11847054. DOI: 10.1016/j.bbadva.2024.100136.


Interactions of human milk oligosaccharides with the immune system.

Slater A, Hickey R, Davey G Front Immunol. 2025; 15:1523829.

PMID: 39877362 PMC: 11772441. DOI: 10.3389/fimmu.2024.1523829.


Effects of Human Milk Oligosaccharide 2'-Fucosyllactose Ingestion on Weight Loss and Markers of Health.

Ko J, Yoo C, Xing D, Chun J, Gonzalez D, Dickerson B Nutrients. 2024; 16(19).

PMID: 39408354 PMC: 11478354. DOI: 10.3390/nu16193387.


The Role of Milk Oligosaccharides in Enhancing Intestinal Microbiota, Intestinal Integrity, and Immune Function in Pigs: A Comparative Review.

Gormley A, Garavito-Duarte Y, Kim S Biology (Basel). 2024; 13(9).

PMID: 39336091 PMC: 11428639. DOI: 10.3390/biology13090663.


Recent advances of 3-fucosyllactose in health effects and production.

Du Z, Li Z, Guang C, Zhu Y, Mu W Arch Microbiol. 2024; 206(9):378.

PMID: 39143417 DOI: 10.1007/s00203-024-04104-2.